Displaying 1 publication

Abstract:
Sort:
  1. Nadarajan VS, Laing AA, Saad SM, Usin M
    Vox Sang, 2012 Jan;102(1):65-71.
    PMID: 21592136 DOI: 10.1111/j.1423-0410.2011.01507.x
    Appropriate screening for irregular red-cell antibodies is essential for ensuring transfusion compatibility and for antenatal management of mothers at risk of haemolytic disease of the foetus and newborn. Screening for all relevant antibodies is, however, limited by screening cells that do not express antigens present in the patient and donor population. Technology to artificially incorporate antigens into red cells is currently available and may be an option for customizing screening cells.
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links